S-ClassAbout S-Class
U
UNHAI Stock Diagnostic Report
What's next for UnitedHealth after its major Q2 earnings beat?
UnitedHealth Group recorded an earnings surprise in the second quarter of 2026 and raised its annual guidance, accelerating its performance rebound.
View Source Article ↗AI CATALYST SCORE90 / 100Score computed by Sentinel V12
REFERENCE PRICE$421.32Reference entry price at analysis time
01
MARKET SNAPSHOT
Key Indicators at a Glance
02
FUNDAMENTALS
Financial & Fundamental Analysis
In the second quarter, adjusted EPS of $6.38 exceeded the consensus by $1.46 (30% surprise), demonstrating an acceleration in the turnaround. The adjusted EPS guidance for 2026 has been raised to $19.50–$20.00, and the operating cash flow outlook has also been upgraded, strengthening the fundamentals.
03
TECHNICAL VIEW
Technical Position & Response Criteria
With an RSI of 67.4, the stock has entered a short-term overbought zone, and it is recommended to confirm support levels before considering additional purchases.
04
CATALYST & STRATEGY
Catalyst Analysis & Forward Strategy
The key performance results for Q2 confirmed the company's turnaround momentum through an earnings beat and the management's upward revision of guidance for 2026.
05
PROOF OF WORK
Analysis Point vs. Subsequent Price Action
INITIAL · At Analysis (2026-07-28)
FINAL · Current/Verified
Renders the actual stored OHLC data directly in your browser.